Jun 26, 2024 · Mircera injection is an erythropoiesis-stimulating agent (ESA) that contains epoetin beta and methoxy polyethylene glycol which may be used to treat anemia associated with …

It works by signaling the bone marrow to make more red blood cells. Methoxy polyethylene glycol -epoetin beta helps to reverse anemia. It also helps to reduce the need for blood...

The recommended starting dose of MIRCERA ® for the treatment of anemia in adult patients with CKD who are not currently treated with an ESA is 0.6 mcg/kg body weight administered once …

MIRCERA ® is a long-acting erythropoiesis-stimulating agent (ESA) used for the treatment of anemia associated with chronic kidney disease (CKD). Due to its specific mode of action, …

Learn about the side effects of Mircera (epoetin beta-methoxy polyethylene glycol), from common to rare, for consumers and healthcare professionals.

MIRCERA (methoxy polyethylene glycol-epoetin beta) injection, for intravenous or subcutaneous use Initial U.S. Approval: 2007 WARNING: ESAs INCREASE THE RISK OF DEATH, …

Mircera is a prescription medicine used to treat anemia. People with anemia have a lower-than-normal number of RBCs. Mircera works like the human protein called erythropoietin to help …

Jun 5, 2024 · Administer supplemental iron therapy ... Injection: 30 mcg, 50 mcg, 75 mcg, 100 mcg, 120 mcg, 150 mcg, 200 mcg, or 250 mcg in 0.3 mL clear, colorless to slightly yellowish …

In adult patients, Mircera is administered by subcutaneous or intravenous injection (2.2). Initial Treatment: 0.6 mcg/kg body weight administered once every two weeks (2.2). Conversion from...

Sep 10, 2023 · Mircera is a medication that's used to treat anemia (low red blood cells) in people who have kidney problems. It's approved for people age 5 years and older who are on dialysis, …